Department of Rheumatology and Immunology, the Second Xiangya Hospital, Central South University, Changsha, China; Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, Changsha, China.
Department of Renal Transplantation, the Second Xiangya Hospital, Central South University, Changsha, China.
Int J Infect Dis. 2024 Apr;141:106962. doi: 10.1016/j.ijid.2024.02.005. Epub 2024 Feb 13.
SARS-CoV-2 pneumonia poses significant challenges to health systems worldwide, particularly, in severe and critical cases. Immunosuppressed renal transplant recipients appear to be at a particularly high risk for severe or critical COVID-19 illness. However, few studies elucidated the risk factors of SARS-CoV-2 pneumonia in renal transplant recipients with COVID-19.
A postinfection cross-sectional survey was conducted in 312 renal transplant recipients and 503 age- and sex-matched controls to explore risk factors for SARS-CoV-2 pneumonia in immunosuppressed renal transplant recipients.
The results showed that renal transplant recipients had a much higher incidence of SARS-CoV-2 pneumonia (48.1%) after infection with the SARS-CoV-2 Omicron variant than controls (5.6%). The multivariate binary logistic regression analysis identified older age, lower creatinine clearance before infection, and higher dose of prednisone before infection as risk factors for SARS-CoV-2 pneumonia in renal transplant recipients. Preexisting renal dysfunction was a major risk factor for SARS-CoV-2 pneumonia, with an odds ratio of 3.27 (1.01-10.61).
Preexisting renal graft dysfunction was a major risk factor for SARS-CoV-2 Omicron variant pneumonia. It is suggested that high-risk renal transplant recipients should undergo computed tomography scanning within 14 days after infection with SARS-CoV-2.
SARS-CoV-2 肺炎对全球卫生系统构成重大挑战,尤其是在重症和危重症病例中。免疫抑制的肾移植受者似乎面临 COVID-19 重症或危重症疾病的特别高风险。然而,很少有研究阐明 COVID-19 肾移植受者中 SARS-CoV-2 肺炎的危险因素。
对 312 例肾移植受者和 503 名年龄和性别匹配的对照者进行了感染后横断面调查,以探讨免疫抑制肾移植受者中 SARS-CoV-2 肺炎的危险因素。
结果表明,肾移植受者在感染 SARS-CoV-2 奥密克戎变异株后 SARS-CoV-2 肺炎的发生率(48.1%)明显高于对照组(5.6%)。多变量二项逻辑回归分析确定年龄较大、感染前肌酐清除率较低和感染前泼尼松剂量较高是肾移植受者 SARS-CoV-2 肺炎的危险因素。感染前存在肾功能障碍是 SARS-CoV-2 肺炎的主要危险因素,优势比为 3.27(1.01-10.61)。
感染前肾移植物功能障碍是 SARS-CoV-2 奥密克戎变异株肺炎的主要危险因素。建议对高风险肾移植受者在感染 SARS-CoV-2 后 14 天内进行计算机断层扫描。